Plain-English translation of NCT00097292 on ClinicalTrials.gov ↗ ·
This is a large research study that follows people who have a higher risk of developing type 1 diabetes — either because they have a close family member with the disease or because their blood shows early warning signs. Researchers will do simple blood tests to look for these warning signs and then monitor participants over time to understand who might develop diabetes and when.
Type 1 diabetes usually appears suddenly, but we now know it develops slowly over time with detectable warning signs in the blood. This study exists to identify people in the early stages so they can be offered prevention or early treatment options before diabetes fully develops.
You likely qualify if…
You likely don't qualify if…
You'll start with a simple blood test at a TrialNet center or through your local doctor to screen for diabetes-related antibodies. If antibodies are found, you'll be invited back for additional testing including a glucose tolerance test and blood sugar measurement. After that, you'll have follow-up visits either once a year or twice a year (depending on your risk level) to monitor whether you're progressing toward diabetes. If you do develop signs of diabetes during the study, researchers may invite you to join a prevention or early treatment trial.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States